Cargando…
Case Report: Severe Immune-Related Cholestatic Hepatitis and Subsequent Pneumonia After Pembrolizumab Therapy in a Geriatic Patient With Metastic Gastric Cancer
Background: Immune checkpoint inhibitors have provided significant clinical benefits to many patients with advanced cancer; however, severe immune-related adverse events (irAEs) have occurred. Detecting and treating irAEs early could improve patient prognoses. Therefore, clinicians and patients shou...
Autores principales: | Yang, Hui, Zhou, Chenfei, Yuan, Fei, Guo, Liting, Yang, Liu, Shi, Yan, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545816/ https://www.ncbi.nlm.nih.gov/pubmed/34712676 http://dx.doi.org/10.3389/fmed.2021.719236 |
Ejemplares similares
-
A Classified Bibliography of Gerontology and Geriatics
por: Perkins, Henrietta
Publicado: (1951) -
Tozinameran: Severe cholestatic hepatitis: case report
Publicado: (2021) -
Voriconazole-Induced Cholestatic Hepatotoxicity in an Immune Competent Patient
por: Mohammed, Yaser, et al.
Publicado: (2022) -
Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis
por: Hong, Alex S, et al.
Publicado: (2022) -
Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma
por: Kurokawa, Kana, et al.
Publicado: (2019)